Fundraising FoxNeuroInitiative
Jacksonville Beach, US · Founded 2014 · Florida LLC
Find your way into NeuroInitiative
Sign up to see every warm intro you have to NeuroInitiative
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NeuroInitiative team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeuroInitiative is a computational biology company that uses a patented AI simulation platform to model neural molecular interactions and prioritize drug targets across aging biology and neurodegeneration. Its platform produced Vincere Biosciences' VB-23, a USP30 inhibitor Parkinson's disease therapy entering Phase 1 clinical trials in 2026.
Founders & leadership
AL
Andrew LeeExecutive
BB
Bahareh BehrouzExecutive
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 2 rounds · 2017
▶$1MraisedNov 2017 · 10 investors · BiotechnologyRule 506(b)
▶$1MraisedNov 2017 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bahareh BehrouzExecutive Officer, Director, Promoter
- Andrew D. LeeExecutive Officer, Director, Promoter
- James L. LiangDirector, Promoter
- Offering amount
- $1.5M
- Amount sold
- $1M
- Minimum investment
- $50K
- Proceeds to insiders
- $180K
- First sale
- Oct 2017
- Incorporated
- Limited Liability Company, Florida, 2014
- Federal exemptions
- 04, 06b
▶$100KraisedFeb 2017 · 4 investors · BiotechnologyRule 506(b)
▶$100KraisedFeb 2017 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James LiangPromoter
- Andrew LeeExecutive Officer
- Bahareh BehrouzExecutive Officer, Director
- Offering amount
- $100K
- Amount sold
- $100K
- Minimum investment
- $25K
- First sale
- Feb 2017
- Incorporated
- Limited Liability Company, Florida, 2014
- Federal exemptions
- 06b, 04.2
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does NeuroInitiative do?
- NeuroInitiative is a computational biology company that uses a patented AI simulation platform to model neural molecular interactions and prioritize drug targets across aging biology and neurodegeneration. Its platform produced Vincere Biosciences' VB-23, a USP30 inhibitor Parkinson's disease therapy entering Phase 1 clinical trials in 2026.
- How much funding has NeuroInitiative raised?
- NeuroInitiative has disclosed $1.1M raised across 2 rounds.
- Where is NeuroInitiative headquartered?
- NeuroInitiative is headquartered in Jacksonville Beach, US.